Kakuhiro Yamaguchi

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 13

Top Venues

Cancers

Thoracic cancer

Respirology (Carlton, Vic.)

PloS one

Hiroshima University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hiroshima University Oct 16 2018

Japan

Assistant Professor :: Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences,

Publications

Kentaro Tokumo, Takeshi Masuda, Taku Nakashima, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Yoshihiro Miyata, Morihito Okada, Hironobu Hamada, Noboru Hattori
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition. Cancers 15 (4) (2023)
Kentaro Tokumo, Takeshi Masuda, Taku Nakashima, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Yoshihiro Miyata, Morihito Okada, Hironobu Hamada, Noboru Hattori
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition. Cancers 15 (4) (2023)
Takashi Oda, Hiroshi Iwamoto, Sachio Takeno, Tomohiro Kawasumi, Kota Takemoto, Manabu Nishida, Nobuyuki Chikuie, Yuichiro Horibe, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Naoko Higaki, Takayuki Taruya, Yasushi Horimasu, Takeshi Masuda, Takao Hamamoto, Taku Nakashima, Takashi Ishino, Tsutomu Ueda, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis. Medicina (Kaunas, Lithuania) 59 (10) (2023)
Kentaro Tokumo, Takeshi Masuda, Taku Nakashima, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Yoshihiro Miyata, Morihito Okada, Hironobu Hamada, Noboru Hattori
Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition. Cancers 15 (4) (2023)
Yu Nakanishi, Hiroshi Iwamoto, Shintaro Miyamoto, Satoshi Nakao, Naoko Higaki, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Naoko Matsumoto, Taku Nakashima, Yojiro Onari, Kazunori Fujitaka, Yoshinori Haruta, Hironobu Hamada, Soichiro Hozawa, Noboru Hattori
Association Between Patient Preference for Inhaler Medications and Asthma Outcomes. Journal of asthma and allergy 15 (2022)
Shoko Isoyama, Kakuhiro Yamaguchi, Nobuki Imano, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Yasushi Nagata, Noboru Hattori
Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy. International journal of clinical oncology 27 (11) (2022)
Takeshi Masuda, Kazunori Fujitaka, Tomoko Suzuki, Kosuke Hamai, Naoko Matsumoto, Mirai Matsumura, Shoko Isoyama, Sayaka Ueno, Mineyo Mito, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Reo Kawano, Ken Masuda, Ryohei Nishino, Nobuhisa Ishikawa, Masahiro Yamasaki, Noboru Hattori
Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1. Thoracic cancer 13 (11) (2022)
Noriaki Ito, Takeshi Masuda, Ikuko Ooka, Takatsune Hosoya, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Taku Nakashima, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
First-line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptor G719S and de novo T790M mutations. Thoracic cancer 13 (5) (2022)
Hiroki Tanahashi, Kakuhiro Yamaguchi, Koji Kurose, Satoshi Nakao, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Toru Oga, Mikio Oka, Noboru Hattori
Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis. Respirology (Carlton, Vic.) (2022)
Naokazu Watari, Kakuhiro Yamaguchi, Takeshi Masuda, Noriaki Ito, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive-stage small cell lung cancer: Two case reports. Thoracic cancer 12 (21) (2021)
Toshihito Otani, Kakuhiro Yamaguchi, Satoshi Nakao, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease. Cancer chemotherapy and pharmacology 88 (5) (2021)
Yu Nakanishi, Yasushi Horimasu, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Takeshi Masuda, Taku Nakashima, Shintaro Miyamoto, Hiroshi Iwamoto, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis. PloS one 16 (6) (2021)
Erika Kobayashi, Kakuhiro Yamaguchi, Rie Nagaoka, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, Michiya Yokozaki, Hiroki Ohge, Hironobu Hamada, Noboru Hattori
Concomitant emphysema might increase the false-negative rate of urinary antigen tests in patients with pneumococcal pneumonia: results from a retrospective study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 40 (4) (2020)

Kakuhiro Yamaguchi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kakuhiro Yamaguchi